# Lexicon Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Feb 2, 2026

- Company: [Lexicon Pharmaceuticals, Inc.](/companies/lxrx.md) (CIK 1062822)
- Form: SCHEDULE 13D/A
- Filed: 2026-02-02
- Accepted by EDGAR: Feb 2, 2026, 21:54 ET
- Period: not reported
- Accession: 0001193125-26-034176
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1062822/000119312526034176/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1062822/000119312526034176/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1062822/000119312526034176/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-034176. Last ingested by Listed: Oct 24, 2026, 15:03 ET. No prices; not investment advice.